US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

102.50

-0.7073-0.69%

Post-market: 102.36-0.1428-0.14%19:30 EDT

Volume:18.72K

Turnover:1.92M

Market Cap:128.12M

PE:- -

High:103.87

Open:103.87

Low:102.00

Close:103.21

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:1.09

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

How do central bankers decide interest rates when inflation is so unpredictable?

Inflation inches higher ahead of interest rates decision

Bank of England under pressure to raise interest rates or risk ‘losing credibility’

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

Cambium Bio Plans New Share Placement to Bolster Capital Base

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Hold interest rates despite inflation risk, Shadow MPC tells Bank of England

Barclays downgrades Scholar Rock on valuation after FDA approval

Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares

Prescient Therapeutics Extends Securities Purchase Plan Deadline

Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Cabaletta Bio Boosts Cash Through Warrant Exercises

Scholar Rock price target raised to $84 from $76 at BMO Capital

Bank of England predicted to raise interest rates this year

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Pharming wins FDA nod to extend Joenja use to younger APDS children

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BBP/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":102.4978,"timestamp":1790971200000,"preClose":103.2051,"halted":0,"volume":18715,"hourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"delay":0,"changeRate":-0.0068533434878703045,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":-0.7073,"latestTime":"10-02 16:00:00 EDT","open":103.87,"high":103.87,"low":102.0005,"amount":1918982.2008,"amplitude":0.018114,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.2051,"sharesOutstanding":600004,"nav":102.494,"aum":128117601.53,"bidAskSpread":0.002439,"postHourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"volumeRatio":1.0888030521127026,"impliedVol":0.2277,"impliedVolPercentile":0.4462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0888030521127026,"shares":1250004,"dividePrice":0,"high":103.87,"amplitude":0.018114,"preClose":103.2051,"low":102.0005,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":102.4978,"eps":0,"divideRate":0,"volume":18715,"delay":0,"ttmEps":0,"open":103.87,"prevYearClose":79.9149,"prevWeekClose":104.6582,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":104.6582,"twentyDayClose":108.8566,"sixtyDayClose":103.6198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667324601","title":"How do central bankers decide interest rates when inflation is so unpredictable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2667324601","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667324601?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:55","pubTimestamp":1789548955,"startTime":"0","endTime":"0","summary":"Andrew Bailey has said an interest rate cut if 'off the table' The Federal Reserve, Bank of England and Bank of Japan all confront the same question this week: how do you set interest rates when inflation is being buffeted by forces well beyond your control?Writes Helen ThomasThree of the world’s most important central banks meet this week, with the Federal Reserve, Bank of England and Bank of Japan all confronting the same question: how do you set interest rates when inflation is being buffeted by forces well beyond your control?","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/01/01JDVVD0N5147SW88N3G465P3B-e1738165980509.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/01/01JDVVD0N5147SW88N3G465P3B-e1738165980509.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/how-do-central-bankers-decide-interest-rates-when-inflation-is-so-unpredictable/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/how-do-central-bankers-decide-interest-rates-when-inflation-is-so-unpredictable/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["PRVS","ADPV","CLIX","IUS","VOTE","FT","FXD","RULE","BSR","RMIF","BKDV","FXL","ILCV","PSC","MAPP","REGL","LCG","EES","LGH","MODL","EQRR","SDOG","TSLP","CAOS","KOMP","PEVC","BAMA","DIVZ","IMCG","UCC","CDC","FLV","FXR","RHTX","VAW","SAMT","TEQI","IJK","CGDV","AVSD","DECU","DFUV","VTV","HIDV","ARP","CGUI","CGUS","ANEW","BBP","MDLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667367067","title":"Inflation inches higher ahead of interest rates decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2667367067","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667367067?lang=en_us&edition=fundamental","pubTime":"2026-09-16 14:17","pubTimestamp":1789539441,"startTime":"0","endTime":"0","summary":"The Bank of England could change interest rates due to high inflation. Inflation inched higher in the year to August, official data has shown, adding to pressures faced by the Bank of England ahead of its interest rate decision on Thursday.The Office for National Statistics  said consumer price index  inflation in the 12 months to August was 3.1 per cent, higher than last month’s reading of 2.9 per cent.The ONS also said services inflation was unchanged at 3.4 per cent, a reading closely monitored by the Bank as it provides some evidence on underlying price pressures in the UK economy.Food price inflation remained low at around 1.3 per cent while core inflation, which strips out volatile items from the consumer basket, rose by 2.6 per cent.“Sharp price rises for petrol and diesel pushed inflation up again in August,” said Grant Fitzner, chief economist at the ONS.“In difficult times, we need a serious government with a plan, not amateurs with a bunch of pet projects,” Griffith said.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/06/Bank-of-England-is-carrying-out-a-private-credit-stress-test.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/06/Bank-of-England-is-carrying-out-a-private-credit-stress-test.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/inflation-inches-higher-ahead-of-interest-rates-decision/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/inflation-inches-higher-ahead-of-interest-rates-decision/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["ILCV","KOMP","EES","VAW","ARP","SDOG","CGDV","MODL","HIDV","CGUS","REGL","RMIF","PSC","EQRR","ADPV","RULE","IMCG","BAMA","LGH","RHTX","BSR","LCG","CPI","SAMT","FLV","BBP","DECU","IUS","TSLP","LRCY","ANEW","RJZ","FT","CGUI","MDLV","FXD","FXL","MAPP","AVSD","CLIX","FXR","DIVZ","DFUV","CDC","CAOS","PRVS","IJK","PEVC","UCC","BKDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667341677","title":"Bank of England under pressure to raise interest rates or risk ‘losing credibility’","url":"https://stock-news.laohu8.com/highlight/detail?id=2667341677","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667341677?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:00","pubTimestamp":1789527600,"startTime":"0","endTime":"0","summary":"The yield on America’s 10-year Treasury – the benchmark for global debt markets – jumped above five per cent for the first time since 2007 in a sign of continued investor unease over the long-term path of inflation.But the UK’s sovereign debt, issued via bonds known as gilts, has been offloaded more aggressively than that of any other major economy, with both long-dated and short-dated securities unceremoniously dumped by traders. The 30-year gilt yield neared six per cent on Tuesday, its highest level since 1997, while shorter-term gilt prices now suggest the Bank will hike rates as many as four times in the next 12 months.Energy price jumps fuel interest rate hike fearsEarlier this week, Saudi Arabia shut down a vital pipeline responsible for carrying oil to the Red Sea, after it was hit in a drone attack. The strike came amid a dramatic re-escalation of tensions in the region, which has revived supply concerns in global energy markets.At $107 a barrel, Brent crude is now trading its","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/Bank-of-England.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/Bank-of-England.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-england-under-pressure-to-raise-interest-rates-or-risk-losing-credibility/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-england-under-pressure-to-raise-interest-rates-or-risk-losing-credibility/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["FXR","TESL","TSYY","TSLL","BK4588","AVSD","IJK","KOMP","BK4585","LRCY","BBEU","ELOL","TEST","TSLQ","TSLT","CAOS","PEVC","TESC","07366","BBP","07766","TSLW","TSLR","TSLZ","BK4582","ISVL","RJZ","CLIX","FLGB","DFUV","TSLS","ANEW","CGDV","TSLO","UCC","09366","TSLI","TSDD","IDEV","TSL","TSLP","TACN","TLA","TSLG","09766","TSLY","CRSH","TSII","FXL","VAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679025","title":"Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679025?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:57","pubTimestamp":1789527450,"startTime":"0","endTime":"0","summary":"The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical Limited, an ASX-listed biotechnology company, has reported changes...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","LNGR","FWD","RSPH","BK4585","XT","DARP","FHLC","BBP","BK4588","IEIH","JDOC","SYNB","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667676156","title":"Cambium Bio Plans New Share Placement to Bolster Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2667676156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667676156?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:52","pubTimestamp":1789523532,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Regeneus Ltd. ( ($AU:CMB) ). Cambium Bio Limited, trading on the ASX under the ticker CMB, is a biotechnology c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","RSPH","LNGR","SYNB","DARP","IEIH","FWD","FHLC","IBB","XT","BK4585","AGNG","JDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["RSPH","MEDI","BBP","SYNB","TBXU","IYH","BMED","XBIX","IDNA","GNMX","GDOC","FRTY","MRNY","PSCH","LABU","TECB","XLVX","BK4585","NVIB","MRNX","IBB","LFSC","BK4588","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965642","title":"Hold interest rates despite inflation risk, Shadow MPC tells Bank of England","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965642","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965642?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:37","pubTimestamp":1789472226,"startTime":"0","endTime":"0","summary":"City AM's Shadow MPC has called for interest rates to be held.  The Bank of England has been urged to hold interest rates even as inflation is set to peak higher than previously expected due to the continuation of the Iran war, City AM’s Shadow Monetary Policy Committee has said.The Bank should leave interest rates unchanged at 3.75 per cent, according to most top economists in the mirror organisation, although some warned the case for waiting on a hike is “thin”.City AM’s Shadow MPC was split 6-3 among those calling for no change in interest rates and those calling for monetary policy to be tightened.“The argument that policymakers need to look past “temporary shocks” is wearing increasingly thin,” he said.Anna Leach – Institute of Directors, chief economistVote: Raise 25 basis pointsLeach said her vote came down to a “close call”. Her decision was determined by inflation remaining above the two per cent target for two years, price expectations remaining elevated and business costs sq","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/bailey-boe-copy-7-e1789468241631.jpg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/bailey-boe-copy-7-e1789468241631.jpg?w=286&h=161&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/hold-interest-rates-despite-inflation-risk-shadow-mpc-tells-bank-of-england/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/hold-interest-rates-despite-inflation-risk-shadow-mpc-tells-bank-of-england/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["MDLV","RMIF","VAW","CGUS","SAMT","CLIX","EQRR","CAOS","BSR","BKDV","SDOG","LCG","PRVS","KOMP","PEVC","ARP","CGDV","CDC","FXL","ANEW","TEQI","UCC","MAPP","DECU","ADPV","BBP","CGUI","DIVZ","IJK","HIDV","BBEU","PSC","AVSD","MODL","RHTX","EES","TSLP","IMCG","FT","FXR","VOTE","FLV","DFUV","REGL","RULE","ILCV","LGH","BAMA","IUS","FXD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","GNMX","MEDI","IDNA","PINK","TACU","SYNB","GDOC","BBP","PSCH","LABU","BMED","FRTY","TBXU","TECB","MRNY","IYH","XLVX","TSPA","LFSC","IEIH","CDIG","IBB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661509","title":"Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661509","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661509?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:47","pubTimestamp":1789447668,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, develops medical therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","FHLC","IBB","BBP","BK4585","LNGR","BK4588","JDOC","RSPH","DARP","SYNB","FWD","XT","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667316690","title":"Prescient Therapeutics Extends Securities Purchase Plan Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667316690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667316690?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:02","pubTimestamp":1789437732,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics Limited ( ($AU:PTX) ) just unveiled an update. Prescient Therapeutics Limited, an ASX-listed biotechnology company trading u...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","FHLC","BK4588","BK4139","JDOC","LENZ","AGNG","SYNB","LNGR","BK4007","BK4539","IBB","FWD","RSPH","BK4585","IEIH","XT","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667694618","title":"Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667694618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667694618?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:16","pubTimestamp":1789431375,"startTime":"0","endTime":"0","summary":"Syntara Limited ( ($AU:SNT) ) has provided an update. Syntara Limited, an ASX-listed clinical-stage biotechnology company based in Sydney, develops...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","RSPH","LNGR","SYNB","DARP","IEIH","FWD","FHLC","IBB","XT","BK4585","BBC","AGNG","JDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","BMED","FWD","GNMX","RSPH","XT","FHLC","IEIH","HTEC","JDOC","SYNB","BK4588","LNGR","DARP","BBP","HELX","BK4585","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TECB","BMED","LABU","IEIH","SYNB","GNMX","XLVX","IYH","NVIB","PINK","MEDI","BBP","MRNY","BK4585","BFRI","IDNA","BK4007","LFSC","MRNX","RSPH","BK4588","GDOC","PSCH","FRTY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","XLVX","BK4585","PINK","LFSC","IEIH","GNMX","MRNY","FRTY","BK4588","GDOC","PSCH","BMED","BBP","IBB","MEDI","LABU","MRNX","IDNA","IYH","SYNB","NVIB","TECB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666613","title":"Cabaletta Bio Boosts Cash Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666613?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389071,"startTime":"0","endTime":"0","summary":"Cabaletta Bio ( ($CABA) ) has provided an update. Cabaletta Bio, a biotechnology company developing engineered immune cell therapies for autoimmune...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BK4585","FWD","BK4139","BK4588","XT","LNGR","JDOC","SYNB","IEIH","FHLC","CABA","RSPH","IBB","BBP","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","XLVX","MRNX","PINK","TBXU","SYNB","GNMX","GDOC","THNR","PSCH","BBP","MEDI","LABU","IDNA","BMED","BK4585","BK4588","MRNY","BK4139","IBRN","SRRK","FRTY","LFSC","IBB","IYH","NVIB","RSPH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500316","title":"Bank of England predicted to raise interest rates this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500316","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667500316?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383602,"startTime":"0","endTime":"0","summary":"The Bank of England could raise interest rates this year.  The Bank of England will raise interest rates to four per cent by the end of the year, a top Wall Street bank has warned.Goldman Sachs has upgraded its interest rate expectations amid concerns that inflation could jump higher than previously expected.The bank said an interest rate hike this year was more likely as it revised up its inflation forecast for the beginning of 2027 to 3.9 per cent. A previous forecast suggested inflation would peak at 3.3 per cent later this year.However, the bank’s forecasters held that rates would be kept at 3.75 per cent when the MPC meets this Thursday. As many as four Bank officials out of the nine-strong MPC could demand higher borrowing rates due to concerns over rising energy prices.Goldman Sachs economists James Moberly and Sven Jari Stehn said there was “some risk” that the MPC signals an upcoming tightening in monetary policy later this week.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/05/Bank-of-England-2-1200x800-2.jpeg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/05/Bank-of-England-2-1200x800-2.jpeg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-england-predicted-to-raise-interest-rates-this-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-england-predicted-to-raise-interest-rates-this-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["07366","BK4582","AVSD","ANEW","TESC","ELOL","RJZ","TEST","TLA","ISVL","TSLL","BBP","TACN","IDEV","TSL","FXR","TSLS","TSLG","TSLI","TSYY","FXL","CAOS","CLIX","TESL","PEVC","FLGB","09766","BK4585","TSLO","KOMP","TSLR","TSLZ","TSLT","BK4588","07766","LRCY","TSLP","DFUV","TSDD","BBEU","CRSH","IJK","TSLW","TSLY","UCC","CGDV","TSLQ","09366","TSII","VAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4179","MRNY","TECB","FRTY","MRNX","IBB","MEDI","BK4139","IDNA","NVIB","TBXU","PINK","BMED","FET","GNMX","GDOC","SYNB","BBP","BK4588","LABU","TLX","LFSC","IYH","RSPH","BK4585","PSCH","IEIH","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","MRNX","GDOC","IYH","FRTY","IEIH","LFSC","SRRK","BK4139","TECB","MEDI","NVIB","TBXU","BK4585","LABU","THNR","SYNB","RSPH","IDNA","GNMX","PINK","PSCH","MRNY","BMED","BK4588","BBP","XLVX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","PINK","NVIB","PSCH","TBXU","BK4588","IBB","MRNY","SYNB","GDOC","GNMX","BMED","XLVX","LFSC","LABU","IYH","FRTY","MEDI","TECB","RSPH","BBP","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}